Technical Analysis for AVTO - Avantogen Oncology Inc

Grade Last Price % Change Price Change
grade D 0.005 11.11% 0.0005
AVTO closed up 11.11 percent on Tuesday, March 26, 2019, on 2 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical AVTO trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup 11.11%
Narrow Range Bar Range Contraction 11.11%
Wide Bands Range Expansion 11.11%
Gapped Up Strength 11.11%
Oversold Stochastic Weakness 11.11%

Older signals for AVTO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Avantogen Oncology, Inc., formerly known as Innovate Oncology, Inc., acquires, develops and seeks to commercialize compounds to treat various types of cancer. Prior to the May 26, 2006, Acquisition, the Company had been pursuing financing for a portfolio of products. The Company focused its resources on three particular product candidates: Chemo-resistance Inhibitor (RP101), Capridine beta and oral paclitaxel. In November 2006, after further evaluation of its existing pipeline, the Company decided to terminate its license agreement for oral paclitaxel. In connection with the May 26, 2006, Acquisition, the Company changed its name to Avantogen Oncology, Inc. from Innovate Oncology, Inc. (Innovate). In November 6, 2006, the Company, Gardant Pharnaceuticals, Inc. (Gardant) and Supratek Pharma, Inc. (SPI) entered into a termination of agreement and releases.
Chemistry Cancer Alcohols Organic Chemistry Ketones Benzamides Benzoates Paclitaxel
Is AVTO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.0556
52 Week Low 0.004
Average Volume 58,105
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0079
10-Day Moving Average 0.0065
Average True Range 0.0038
ADX 20.16
+DI 77.8195
-DI 67.1053
Chandelier Exit (Long, 3 ATRs ) 0.0035
Chandelier Exit (Short, 3 ATRs ) 0.0155
Upper Bollinger Band 0.0147
Lower Bollinger Band 0.0011
Percent B (%b) 0.29
BandWidth 172.151899
MACD Line -0.0017
MACD Signal Line -0.0014
MACD Histogram -0.0003
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0050
Resistance 3 (R3) 0.0050 0.0050 0.0050
Resistance 2 (R2) 0.0050 0.0050 0.0050 0.0050
Resistance 1 (R1) 0.0050 0.0050 0.0050 0.0050 0.0050
Pivot Point 0.0050 0.0050 0.0050 0.0050 0.0050
Support 1 (S1) 0.0050 0.0050 0.0050 0.0050 0.0050
Support 2 (S2) 0.0050 0.0050 0.0050 0.0050
Support 3 (S3) 0.0050 0.0050 0.0050
Support 4 (S4) 0.0050